Recruiting

Observational Study

Sponsor:

Baylor Research Institute

Code:

NCT06352671

Conditions

Aortic Valve Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This standardized prospective long-term outcome analysis will help reaffirm these findings via a multicenter patient cohort and describe the best practices/techniques for stabilization of the autograft and right ventricular outflow tract reconstruction.

Conditions

Aortic Valve Disease

Study ID

NCT06352671

Start date

Oct 12, 2023

Status verified date

Feb, 2026

Completion date

Dec 1, 2026

Anticipated

Primary completion date

Dec 1, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients undergoing Ross procedure at Baylor Scott and White The Heart Hospital, Plano, The University of Pennsylvania, The University of Washington, and Northwestern University.

Exclusion Criteria:

  • Less than 18 years of age
  • Presence of active malignancy
  • Pregnant at the time of surgery
  • Inability to provide informed consent

Study Design

Enrollment

225 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Survival of the patient [ Time Frame: 1 year, 5 year and 10 year ]

Central Contacts and Locations

Central contacts

Bonnie Ostergren

4698144181Bonnie.Ostergren@BSWHealth.org

Locations

Baylor Scott and White Heart Hospital

Recruiting

Plano, Texas, United States, 75093

Contacts

Bonnie Ostergren

4698144181Bonnie.Ostergren@BSWHealth.org

Sarah Hale

4698144845sarah.hale@bswhealth.org

Principal Investigator:

William Brinkman, MD

More Information

Sponsor

Baylor Research Institute

Last update posted

Apr 15, 2026

Last verified

Feb, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Baylor Research Institute on 2026-04-15.